I suspect that should we hear no statement from Esra this week it is unlikely she will return as CEO. If so I'm deeply saddened as I have been a huge fan of hers from day one. She is much admired by investors, industry colleagues , POH staffers and me. She has been an Icon within Aussie Biotech. Since ascending to the position of CEO she has steered the company through a period of incredible growth and achieved much to ensure POH is destined for commercial success. In POHs short history Esra has made an important and lasting contribution and as holders we have much to be thankful to her. Whatever the circumstances of Esra's departure I for one wish her well.
we made the smh..., page-67
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $500 | 250K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 45759211 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 45964683 | 26 |
View Market Depth
| Last trade - 13.36pm 30/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |